PT2143445E - Medicated patch - Google Patents

Medicated patch

Info

Publication number
PT2143445E
PT2143445E PT87519799T PT08751979T PT2143445E PT 2143445 E PT2143445 E PT 2143445E PT 87519799 T PT87519799 T PT 87519799T PT 08751979 T PT08751979 T PT 08751979T PT 2143445 E PT2143445 E PT 2143445E
Authority
PT
Portugal
Prior art keywords
medicated patch
ultraviolet absorber
inflammatory agent
agent
medicated
Prior art date
Application number
PT87519799T
Other languages
Portuguese (pt)
Inventor
Kiyomi Tsuruda
Shigeo Suzuki
Miyuki Kozuma
Original Assignee
Hisamitsu Pharmaceutical Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hisamitsu Pharmaceutical Co filed Critical Hisamitsu Pharmaceutical Co
Publication of PT2143445E publication Critical patent/PT2143445E/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
    • A61K9/7046—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
    • A61K9/7053—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained by reactions only involving carbon to carbon unsaturated bonds, e.g. polyvinyl, polyisobutylene, polystyrene
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/192—Carboxylic acids, e.g. valproic acid having aromatic groups, e.g. sulindac, 2-aryl-propionic acids, ethacrynic acid 
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Dermatology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

A conventional medicated patch containing an anti-inflammatory agent causes a dermatitis or the like on rare occasion by excess irradiation with light. For overcoming the problem, a medicated patch is provided, which comprises an anti-inflammatory agent, BM-DBM as an ultraviolet absorber, and hexyl laurate as an agent for accelerating the migration of the ultraviolet absorber into the skin in an adhesive base material thereof.
PT87519799T 2007-04-23 2008-04-23 Medicated patch PT2143445E (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP2007113200 2007-04-23

Publications (1)

Publication Number Publication Date
PT2143445E true PT2143445E (en) 2013-12-13

Family

ID=39925721

Family Applications (1)

Application Number Title Priority Date Filing Date
PT87519799T PT2143445E (en) 2007-04-23 2008-04-23 Medicated patch

Country Status (10)

Country Link
US (1) US20100239639A1 (en)
EP (1) EP2143445B1 (en)
JP (1) JP5374365B2 (en)
CY (1) CY1114653T1 (en)
DK (1) DK2143445T3 (en)
ES (1) ES2436691T3 (en)
PL (1) PL2143445T3 (en)
PT (1) PT2143445E (en)
SI (1) SI2143445T1 (en)
WO (1) WO2008133272A1 (en)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP5430905B2 (en) * 2008-10-22 2014-03-05 久光製薬株式会社 Patch
TWI482645B (en) * 2010-01-07 2015-05-01 Teikoku Seiyaku Kk External oily plaster containing diclofenac hydroxyethylpyrrolidine
CN104394858B (en) * 2012-06-20 2017-03-22 久光制药株式会社 Percutaneous absorption promoter and skin patch comprising same
MY179230A (en) * 2014-02-27 2020-11-02 Hisamitsu Pharmaceutical Co Ketoprofen-containing poultice
WO2019150594A1 (en) * 2018-01-31 2019-08-08 株式会社ユニッシュ Transdermal phosphatidylcholine preparation

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS60155111A (en) * 1983-10-20 1985-08-15 Hisamitsu Pharmaceut Co Inc Stable pharmaceutical for external use containing "ketoprofen(r)"
DE3517080A1 (en) * 1985-05-11 1986-11-13 Bayer Ag, 5090 Leverkusen COMPONENT FOR THERAPEUTIC ACTIVE SUBSTANCE DELIVERY SYSTEMS
JPH062666B2 (en) * 1986-04-11 1994-01-12 積水化学工業株式会社 Patch
JPH062667B2 (en) * 1986-04-11 1994-01-12 積水化学工業株式会社 Patch
JP3661706B2 (en) * 1993-10-28 2005-06-22 三省製薬株式会社 Topical skin preparation
JPH09169658A (en) 1995-12-19 1997-06-30 Pola Chem Ind Inc Antiinflammatory preparation for external use for skin
US6967023B1 (en) * 2000-01-10 2005-11-22 Foamix, Ltd. Pharmaceutical and cosmetic carrier or composition for topical application
CA2424579C (en) * 2000-03-17 2009-11-03 Hisamitsu Pharmaceuticals Co., Inc. Ultraviolet-screening patch
EP1400240B1 (en) * 2001-05-31 2010-04-21 Hisamitsu Pharmaceutical Co., Inc. Percutaneously absorbable patches
GB0322342D0 (en) * 2003-09-23 2003-10-22 Gamble Reed Skin patch
TWI341736B (en) * 2003-12-26 2011-05-11 Hisamitsu Pharmaceutical Co Anti-infammatory adhesive preparations
TWI414320B (en) * 2004-05-13 2013-11-11 Hisamitsu Pharmaceutical Co A transdermal formulation comprising non-steroid anti-inflammation drugs
US8551979B2 (en) * 2004-11-05 2013-10-08 Lead Chemical Co., Ltd. Nonaqueous preparation for percutaneous absorption containing nonsteroidal anti-inflammatory analgesic
JP5117846B2 (en) * 2005-02-25 2013-01-16 久光製薬株式会社 External preparation containing anti-inflammatory agent and soybean lecithin
PL1872796T3 (en) * 2005-02-25 2012-01-31 Hisamitsu Pharmaceutical Co Transdermal preparation for external use containing nonsteroidal antiinflammatory/analgesic agent

Also Published As

Publication number Publication date
WO2008133272A1 (en) 2008-11-06
JP5374365B2 (en) 2013-12-25
ES2436691T3 (en) 2014-01-03
JPWO2008133272A1 (en) 2010-07-29
EP2143445B1 (en) 2013-09-04
DK2143445T3 (en) 2013-11-25
EP2143445A4 (en) 2010-11-03
US20100239639A1 (en) 2010-09-23
PL2143445T3 (en) 2014-01-31
CY1114653T1 (en) 2016-12-14
EP2143445A1 (en) 2010-01-13
SI2143445T1 (en) 2013-12-31

Similar Documents

Publication Publication Date Title
PT2143445E (en) Medicated patch
MX2017015550A (en) Methods of bonding hardware to vehicular glass.
EP1970696A3 (en) Ultraviolet irradiation apparatus, curing reaction detector used for the same and method for curing an ultraviolet curing resin using the curing reaction detector
WO2007120630A3 (en) Activated anaerobic adhesive and use thereof
EP1897700A3 (en) Method of manufacturing a security device
PL1756241T3 (en) Method for forming structures using an encapsulated adhesive material
WO2007048105A3 (en) Curable bone substitute
MX339255B (en) Oxidatitive photoactivated skin rejeuvenation composition comprising hyaluronic acid, glucosamine, or allantoin.
WO2010047923A3 (en) Methods and systems for treating breast cancer using external beam radiation
GB0420888D0 (en) Compounds and uses
WO2008152956A1 (en) Photocurable pressure-sensitive adhesive composition
AR063853A1 (en) METHOD TO TREAT HAIR
TW200641038A (en) Polylactic acid cross-linked material and method for making the same
TW200613327A (en) Melts
GB0228647D0 (en) Polyeric material containing a latent acid
MX345130B (en) Enhanced efficiency of sunscreen compositions.
BRPI0506431A (en) irradiation curable lamination adhesive composition, laminated material, process for forming the same
WO2009069562A1 (en) Resin composition
WO2009004597A3 (en) Multicolored linear light source
WO2009104192A3 (en) Disposable measuring device for uv radiation
CL2008003073A1 (en) Method and system for coating substrate comprising vertically orienting the substrate between bottom curtain and spray gun, coating the substrate with radiation curable liquid coating composition, atomizing the composition through the gun and curing the composition by exposure to ionizing radiation and / or or actinic.
TW200705096A (en) Photosensitive composition, pattern forming method using the photosensitive composition and compound for use in the photosensitive composition
WO2010003511A3 (en) Compact uv irradiation module
WO2012044423A3 (en) Light directing expandable envelope
WO2009116867A3 (en) A target material, a source, an euv lithographic apparatus and a device manufacturing method using the same